Clinical Trial Update: One-year, Open Extension to Evaluate the Treatment of Patients With Castration-Resistant Prostate Cancer With YONSA™ [Phase 2]

View source ↗

Summary

Phase 2 open-extension study evaluating YONSA in metastatic prostate cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• YONSA (abiraterone acetate)

Snippet

Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Metastatic Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-07-22